PHXM
PHAXIAM Therapeutics S.A. - ADR

2
Loading...
Loading...
News
all
press releases
Phaxiam Therapeutics effects delisting of ADSs from Nasdaq
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
More News
News Placeholder
Head to Head Survey: PHAXIAM Therapeutics (NASDAQ:PHXM) vs. Inhibrx (NASDAQ:INBX)
Inhibrx (NASDAQ:INBX Get Free Report) and PHAXIAM Therapeutics (NASDAQ:PHXM Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare...
Zolmax·1y ago
News Placeholder
PHAXIAM Therapeutics S.A. (NASDAQ:PHXM) Short Interest Down 68.0% in February
PHAXIAM Therapeutics S.A. (NASDAQ:PHXM Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling...
Zolmax·2y ago
News Placeholder
Head-To-Head Comparison: PHAXIAM Therapeutics (NASDAQ:PHXM) & Inhibikase Therapeutics (NYSE:IKT)
PHAXIAM Therapeutics (NASDAQ:PHXM Get Free Report) and Inhibikase Therapeutics (NYSE:IKT Get Free Report) are both small-cap medical companies, but which is the better business? We...
Zolmax·2y ago
News Placeholder
PHAXIAM Therapeutics (NASDAQ:PHXM) Trading Down 9.4%
PHAXIAM Therapeutics S.A. (NASDAQ:PHXM Get Free Report)s share price dropped 9.4% on Thursday . The stock traded as low as $4.70 and last traded at $4.70. Approximately 440 shares were...
Zolmax·2y ago

Latest PHXM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.